Schilling, Sandra
Pradhan, Ajay
Heesch, Amelie
Helbig, Andrea
Blennow, Kaj
Koch, Christian
Bertgen, Lea
Koo, Edward H.
Brinkmalm, Gunnar
Zetterberg, Henrik
Kins, Stefan
Eggert, Simone
Funding for this research was provided by:
Swedish State Support for Clinical Research (#AFLGBG-71320)
Alzheimer Forschung Initiative (19084)
Deutsche Forschungsgemeinschaft (Kl 819/9-1)
BioComp
TU Nachwuchsring
Swedish Research Council (#2018-02532)
European Union's Horizon Europe research and innovation programme (No 101053962)
Alzheimer's Drug Discovery Foundation (#201809-2016862)
AD Strategic Fund and the Alzheimer's Association (#ADSF-21-831376-C, #ADSF-21-831381-C, #ADSF-21-831377-C)
the Bluefield Project, the Olav Thon Foundation, the Erling-Persson Family Foundation, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden (#F02022-0270)
HORIZON EUROPE Marie Sklodowska-Curie Actions (No 860197 (MIRIADE))
UK Dementia Research Institute (UKDRI-1003)
Max Planck Institute for Multidisciplinary Sciences
Article History
Received: 9 March 2023
Accepted: 4 May 2023
First Online: 1 June 2023
Conflict of interest
: The authors declare that they have no conflict of interest.